Echelon Biosciences Inc.
SEARCH






ASSAYS AND REAGENTS FOR DRUG DISCOVERY IN LIPID SIGNALING PATHWAYS
FORUMS
PRODUCT CATEGORIES
Antibodies and Lipid Recognition Proteins
Assays
Enzymes
Heme Pathway
Inhibitors
Inositol Phosphates
Intracellular Lipid Delivery Systems
Isoprenoids
Lipid-Protein Interaction Tools
Lipids
Lysophospholipid Products
MEP Pathway intermediates
Phosphoinositide Reagents and Derivatives
Phospholipase Substrates
Protein Kinases & Phosphatases
Sphingolipid Products
PURCHASE ASSISTANCE
Order Status
My Quotation
My Account
DISTRIBUTORS
TECHNICAL SUPPORT / FAQ
NEWS
TECHNICAL DATA SHEETS &     PROTOCOLS
PUBLICATIONS
BROWSE BY PATHWAY
FEEDBACK
SUBMIT PRODUCT IDEAS
Direct:801-588-0455
Fax:801-588-0497
       Category : Inhibitors :   Akt Inhibitors : Akt Inhibitor (KP372-1)



Click to enlarge

Product Name

Catalog Number

Unit Price


KP372-1 directly inhibits the kinase activities of Akt, PDK1 and Flt3 (Fms-like tyrosine kinase 3), which are aberrantly activated in acute myelogenous leukemia (AML). It is a cell permeant inhibitor that decreases the colony-forming ability of AML cells (IC50 < 200 nM) with minimal cytoxic effects on normal hematopoietic progenitor cells. KP372-1 has also been shown to suppress cell proliferation and induce apoptosis in thyroid cancer cells and gliobastoma.
Formula:
—C10H4N6O, FW: 224.2 (1:1 mixture of isomers)
Solubility:
—Water: insoluble, DMSO: 5 mg/mL
Storage:
—dry between 2-8oC. Stock solutions should be stored frozen (-20oC).
References:
Br. J. Cancer, 2005
Cancer Res.,2006
—Mol. CncerTther., 2006
Catalog:
Inhibitors
 
Additional Informaiton
  --
B-0102